Key Market Insights

Presently, over 220 cell cytometers are currently available for use across wide range of clinical studies and research applications; majority of these have been developed by companies based in the US

The market landscape features a variety of cell cytometers that make use of combinations of multiple detection mechanisms and color channels to count and sort cells

In pursuit of building a competitive edge, stakeholders are making an active effort to incorporate advanced features in their respective portfolio of cytometers and comply with evolving industry benchmarks

With the growing adoption of cytometers, several industry players have signed multiple agreements for high throughput flow cytometers and image cytometers

Having realized the opportunity in the cell cytometry segment, several investors have collectively invested multi-million dollars to aid the development of cytometers with advanced features

Both industry and non-industry players have participated in various global events to discuss the research outcomes, affiliated challenges as well as opportunities in the cell cytometry industry

More than 500 patents related to cell cytometers have been granted / filed by academia and industry stakeholders in the last five years; majority of these are patent applications

The market is expected to grow at a CAGR of 9.9%; the projected market opportunity is likely to be well distributed across different types of cytometers; North America is likely to capture majority of the current market share

Request a sample copy of the Cell Cytometry Market report

https://www.rootsanalysis.com/reports/cell-cytometry-market/request-sample.html

Table of Contents

1. PREFACE

1.1. Scope of the Report

1.2. Market Segmentation

1.3. Research Methodology

1.4. Key Questions Answered

1.5. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3.1. Chapter Overview

3.2. Cell Cytometry

3.2.1. Flow Cytometry

3.2.1.1. High Throughput Flow Cytometry

3.2.1.1. Image Cytometry

3.3. Advantages and Limitations of Cell Cytometry

3.4. Prevalent Trends Related to Cell Cytometry

3.4.1. Key Historical Trends

3.4.2. Emerging Focus Area

3.4.3. Geographical Activity

4. HIGH THROUGHPUT FLOW CYTOMETERS: MARKET LANDSCAPE

4.1. Chapter Overview

4.2. High Throughput Flow Cytometers: Overall Market Landscape

4.2.1. Analysis by Type of High Throughput Flow Cytometer

4.2.2. Analysis by Throughput Rate

4.2.3. Analysis by Detection Rate

4.2.4. Analysis by Type of Plate Format

4.2.5. Analysis by Number of Color Channels

4.2.6. Analysis by Number of Detection Channels

4.2.7. Analysis by Number of Laser Channels

4.2.8. Analysis by Product Dimensions

4.2.9. Analysis by Sample Volume

4.2.10. Analysis by Type of Detection Mechanism

4.2.11. Analysis by Application(s)

4.3. High Throughput Flow Cytometers: Developer Landscape

4.3.1. Analysis by Year of Establishment

4.3.2. Analysis by Company Size

4.3.3. Analysis by Location of Headquarters

4.3.4. Most Active Players: Analysis by Number of Products Offered

5. PRODUCT COMPETITIVENESS ANALYSIS: HIGH THROUGHPUT FLOW CYTOMETERS

5.1. Chapter Overview

5.2. Assumptions / Key Parameters

5.3. Methodology

5.4. Product Competitiveness Analysis

5.4.1. Product Competitiveness Analysis: High Throughput Flow Cytometers offered by Developers based in North America

5.4.2. Product Competitiveness Analysis: High Throughput Flow Cytometers offered by Developers based in Europe and Asia

6. IMAGE CYTOMETERS: MARKET LANDSCAPE

6.1. Chapter Overview

6.2. Image Cytometers: Overall Market Landscape

6.2.1. Analysis by Type of Image Cytometer

6.2.2. Analysis by Processing Time

6.2.3. Analysis by Type of Plate Format

6.2.4. Analysis by Output Format

6.2.5. Analysis by Sample Volume

6.2.6. Analysis by Product Dimensions

6.2.7. Analysis by Application(s)

6.3. Image Cytometers: Developer Landscape

6.3.1. Analysis by Year of Establishment

6.3.2. Analysis by Company Size

6.3.3. Analysis by Location of Headquarters

6.3.4. Most Active Players: Analysis by Number of Products Offered

7. PRODUCT COMPETITIVENESS ANALYSIS: IMAGE CYTOMETERS

7.1. Chapter Overview

7.2. Assumptions / Key Parameters

7.3. Methodology

7.4. Product Competitiveness Analysis

7.4.1. Product Competitiveness Analysis: Image Cytometers offered by Developers based in North America

7.4.2. Product Competitiveness Analysis: Image Cytometers offered by Developers based in Europe and Asia

8. GLOBAL CELL CYTOMETRY: COMPANY PROFILES

8.1. Chapter Overview

8.2. Agilent

8.2.1. Company Overview

8.2.2. Recent Developments and Future Outlook

8.3. Beckman Coulter Life Sciences

8.3.1. Company Overview

8.3.2. Recent Developments and Future Outlook

8.4. Becton Dickinson

8.4.1. Company Overview

8.4.2. Recent Developments and Future Outlook

8.5. Bio-Rad

8.5.1. Company Overview

8.5.2. Recent Developments and Future Outlook

8.6. Chemometec

8.6.1. Company Overview

8.6.2. Recent Developments and Future Outlook

8.7. Milkotronic

8.7.1. Company Overview

8.7.2. Recent Developments and Future Outlook

8.8. Nexcelom Bioscience

8.8.1. Company Overview

8.8.2. Recent Developments and Future Outlook

8.9. Sartorius

8.9.1. Company Overview

8.9.2. Recent Developments and Future Outlook

8.10. Sony Biotechnology

8.10.1. Company Overview

8.10.2. Recent Developments and Future Outlook

8.11. ThermoFisher Scientific

8.11.1. Company Overview

8.11.2. Recent Developments and Future Outlook

8.12. Union Biometrica

8.12.1. Company Overview

8.12.2. Recent Developments and Future Outlook

9. GLOBAL CELL CYTOMETYRY: PARTNERSHIPS AND COLLABORATIONS

9.1. Chapter Overview

9.2. Partnership Models

9.3. List of Partnerships and Collaborations

9.3.1. Analysis by Year of Partnership

9.3.2. Analysis by Type of Partnership

9.3.3. Most Active Players: Analysis by Number of Partnerships

9.3.4. Regional Analysis

9.3.5. Intercontinental and Intracontinental Agreements

10. RECENT DEVELOPMENTS

10.1. Chapter Overview

10.2. Global Cell Cytometry: Funding and Investment Analysis

10.2.1. Types of Funding

10.2.2. List of Funding and Investments

10.2.3. Analysis by Year of Investment

10.2.4. Analysis by Type of Funding

10.2.5. Analysis by Amount Invested

10.2.6. Most Active Players: Analysis by Number of Funding Instances

10.2.7. Most Active Players: Analysis by Amount Raised

10.2.8. Most Active Investors: Analysis by Number of Funding Instances

10.3. Global Cell Cytometry: Global Event Analysis

10.3.1. List of Global Events

10.3.1.1. Analysis by Year of Event

10.3.1.2. Analysis by Event Platform

10.3.1.3. Analysis by Type of Events

10.3.1.4. Analysis by Geography

10.3.1.5. Most Active Event Organizers: Analysis by Number of Events

10.3.1.6. Most Active Organizations: Analysis by Number of Participants

10.4. Concluding Remarks